Zou Bin

Company: Axcynsis

Job title: Chief Scientific Officer

Seminars:

Novel & Dual Payloads: Assessing Linker Conjugation Technologies That Encourage Flexibility in Payloads 3:50 pm

Evaluating the right ratios, the advantages of releasing drugs in specific ratios, and which combination of drugs make sense when considering dual payloads Discussing how novel payloads hold promise to overcome drug resistance Advancing cytoxic or immune-stimulating payloads with novel MoAsRead more

day: Day One P3